{"disease":{"id":"niemann-pick-disease-type-c-npc","name":"niemann pick disease type c npc"},"drugs":{"marketed":[{"drug_id":"arimoclomol","indication_name":"Niemann-Pick disease type C (NPC)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Miplyffa","generic_name":"ARIMOCLOMOL","company_name":"Zevra Denmark","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":53,"revenue":null,"mechanism":"Miplyffa works by activating heat shock proteins to help protect cells from damage."},{"drug_id":"levacetylleucine","indication_name":"Niemann-Pick disease type C (NPC)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aqneursa","generic_name":"LEVACETYLLEUCINE","company_name":"Intrabio","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":46,"revenue":null,"mechanism":"Aqneursa works by modifying the activity of a specific enzyme involved in the breakdown of fatty substances in the body."}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}